ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLST Clrstar (DI/S)

48.50
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clrstar (DI/S) LSE:CLST London Ordinary Share KYG2294M1050 ORD USD0.0001 (DI / REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 48.50 45.00 52.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

ClearStar,Inc. Full Year Results (6787A)

28/03/2017 7:01am

UK Regulatory


Clrstar (DI/S) (LSE:CLST)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Clrstar (DI/S) Charts.

TIDMCLST TIDMCLSU

RNS Number : 6787A

ClearStar,Inc.

28 March 2017

28 March 2017

ClearStar, Inc.

("ClearStar" or the "Company")

Preliminary Results

ClearStar (AIM: CLSU and CLST), a leading technology and service provider to the background check industry, announces its unaudited results for the year ended 31 December 2016.

Financial Highlights

   --      Revenue increased by 3% to $16.0 million (2015: $15.5 million) 
   --      Gross margin maintained at 61.3% (2015: 61.2%) 
   --      General and administrative expenses reduced by 7.8% to $7.5 million (2015: $8.2 million) 
   --      EBITDA improved by $290,000 to a $666,000 loss (2015: $956,000 loss) 

-- As of 31 December 2016, the Company had net cash of $2.4 million (30 June 2016: $3.1 million; 31 December 2015: $3.9 million)

Operational Highlights

Direct Services

-- Significant progress in direct services resulting in organic revenue growth of approximately 77% to $1.9 million (2015: $1.1 million)

   --     Successful in targeting larger, higher-volume direct clients, with particular demand in the transportation industry 

-- Benefitted from the strengthening direct services sales team and introduction of the new ClearID and ClearContact solutions

-- Strong organic growth mitigated the contraction in revenue due to the attrition of clients gained through the SingleSource acquisition, with total Direct Services Division revenues slightly above the previous year at $3.80 million (2015: $3.77 million)

Channel Partner and Consumer Reporting Agencies ("CRAs")

-- Channel Partner and Consumer Reporting Agency revenue grew by 4% to $12.2 million (2015: $11.7 million) with increased demand for ClearStar's technologically-differentiated suite of products and solutions

-- Largest service offering by revenue was medical information services, which accounted for 39% of division sales

-- Ongoing improvement to offering, including adding new integration points, product development in areas of data distribution and improvements to user interface

Technology and Product Advancement

-- Gained initial traction from the development of its global platform to satisfy interface, compliance and architectural demands outside the US

-- The Company's clinical testing service was made available via ClearStar's proprietary WebCCF technology and number of collection sites increased to over 15,000

Post period

-- As announced today, ClearStar has been awarded a contract by IntelliCentrics, a global leader in vendor credentialing in the healthcare industry, to provide its medical information services to streamline the drug and titer testing process

Robert Vale, CEO of ClearStar, commented: "These results demonstrate that ClearStar's underlying businesses are robust and continue to deliver revenue growth. 2016 was a significant year for us as we streamlined our business, strengthened our direct sales team and launched our global platform. ClearStar now provides a suite of advanced services, directly and indirectly through our Channel Partner and CRA customers, on a global basis.

As a result, we entered 2017 well positioned with a stronger client base and more comprehensive service offering compared with the previous year. The fluidity of the labour market continues to expand thereby increasing the demand for our direct services and providing new opportunities for revenue generation. Our global platform, Sphere, is gaining traction, with the strong initial client response, strengthening our belief that we can generate meaningful global revenue in 2017. Consequently, we are confident of delivering continued growth and shareholder value, and we look forward to updating the market as the year progresses."

Enquiries:

 
 ClearStar, Inc. 
----------------------------------  ----------------- 
 Robert Vale, Chief Executive 
  Officer 
  David Pattillo, Chief Financial 
  Officer                            +1 770 416 1900 
----------------------------------  ----------------- 
 
 finnCap Ltd. 
----------------------------------  ----------------- 
 Jonny Franklin-Adams, Simon 
  Hicks - Corporate Finance 
  Christian Hobart, Abigail 
  Wayne - Corporate Broking          +44 20 7220 0500 
----------------------------------  ----------------- 
 
 Luther Pendragon Ltd. 
----------------------------------  ----------------- 
 Harry Chathli, Claire Norbury       +44 20 7618 9100 
----------------------------------  ----------------- 
 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

About ClearStar

ClearStar, Inc. is a leading and trusted background check technology, strategic services and decision-making information provider to employers and background screening companies.

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

Operational Review

During the twelve months ended 31 December 2016, the Company achieved 3% revenue growth to $16.0 million (2015: $15.5 million). This was based on processing approximately 7.8 million screening services (2015: 7.2 million) on over 2.3 million people (2015: 2.2 million) that were provided to over 28,000 end-users (2015: 28,000).

Direct Services Division

During the period, ClearStar strengthened and expanded its direct sales and services team to capitalise on attractive market opportunities within the growing US screening market. In particular, the Company recruited employees with significant experience and expertise in engaging with large companies, which is ClearStar's primary target market. As a result, Direct Services Division organic revenues increased by 77% to $1.9 million (2015: $1.1 million), and the Company was successful in 'upscaling' its client base by targeting larger, higher-volume direct clients, with particular demand in the transportation industry. In addition, the Company is continuing to benefit from the changing demands of the ever-increasing 'gig economy' and casual and transitory nature of the labour market.

ClearStar commenced the on-boarding process for the three-year contract, signed at the end of 2015, with a leading global relocation and specialised logistics solutions provider, which includes the maiden deployment of the Company's biometric recognition software and electronic address book solution that were also launched during the period as ClearID and ClearContact. The Company is receiving increasing interest in these mobile-centric solutions from employers that rely on remote hiring or where large numbers of temporary workers are employed on a sustained basis, and commenced several trials with potential clients. Significantly, this customer is also making an initial deployment of the Company's global platform, Sphere, as described below.

Within direct services, the sales of direct medical information services increased by 56% to $745,000 (2015: $478,000), and is now serving around 600 clients.

As previously announced, the Company experienced attrition among its acquired SingleSource client base as a result of a large proportion of the smaller clients choosing not to invest in upgrading their compliance standards to meet ClearStar's requirements. However, this was largely mitigated by the growth in organic sales resulting in total Direct Services Division revenues of $3.80 million (2015: $3.77 million).

Post period, as announced today, ClearStar has been awarded a contract by IntelliCentrics, the healthcare industry leader with over 10,000 distinct installations of vendor credentialing across the US, Canada and the UK. ClearStar's automated titer and drug screening solution, made available via the Company's proprietary WebCCF technology, will be integrated into IntelliCentrics' SEC(3) URE program for hospitals and healthcare organisations. The SEC(3) URE healthcare experience is designed to allow hospitals to control access by healthcare industry representatives by ensuring only those that comply with the hospital's specific policies gain access to patient sensitive or restricted areas. The Company's automated order placement, registration and automatic transmission solution will eliminate the traditional paper-intensive forms and inefficient way of collating data for titer and drug screening tests.

Channel Partners and Consumer Reporting Agencies ("CRAs") Division

In this division, ClearStar provides white labelling technology. Data logistics services are provided to Channel Partners and CRAs who use the Company's technology to perform background checks on job applicants and to provide services to organisations for the purpose of medical testing, mainly for employees.

The division continued to be the largest contributor to overall revenues. Sales for 2016 increased by 4% to $12.2 million (2015: $11.8 million). This was primarily as a result of increased business from some of the Company's largest clients. The primary services contributor to revenues was medical information services, which consisted mostly of drug testing but also clinical testing and occupational testing, which accounted for $4.9 million (2015: $4.8 million) of the division's sales. The Company increased the number of employers that it provides its medical testing and results review services to over 14,500.

Technology and Product Advancement

During the period, the Company launched its global platform, Sphere, which was developed to satisfy interface, compliance and architectural demands outside the US. The Company has begun processing international records on Sphere, including initial records for its largest direct sales customer. The Company is receiving increasing interest in its global solutions from US-based organisations that have global operations or that require access to the global records of prospective employees as well as businesses based outside of the US. Management is confident of more widespread usage of Sphere in 2017 and expects meaningful revenue contribution from its global customers.

ClearStar achieved certification from the U.S. Department of Commerce under the EU-U.S. Privacy Shield for the transfer of personally identifiable information (PII) from the European Union to the United States. The EU-U.S. Privacy Shield Framework was designed by the U.S. Department of Commerce and the European Commission to provide companies on both sides of the Atlantic with a mechanism to comply with EU data protection requirements when transferring personal data from the EU to the US. The certification represents a further testament to the strength of ClearStar's privacy and compliance standards as well as differentiating the Company from its competitors.

The Company grew its network of collection sites for its medical information services to over 15,000 and made its clinical testing service available via its proprietary WebCCF technology. WebCCF is ClearStar's online laboratory registration and electronic custody and control form technology with mobile wallet-integration to enable a completely paperless screening process, which expedites the on-boarding of new hires and efficiently manages the ongoing compliance testing of the workforce. The Company believes that the ease-of-use of this solution is a market differentiator for ClearStar and that sales in clinical testing will increase as result of its availability via WebCCF.

Financial Review

The Company continued to achieve revenue growth with total revenues increasing by 3% for the year ended 31 December 2016 to $16.0 million compared with $15.5 million for the year ended 31 December 2015.

Gross profit increased by 4% to $9.8 million (2015: $9.5 million) and gross profit margin was maintained at 61.3% (2015: 61.2%). This increase was primarily due to achieving greater purchase economies.

Total operating expenses, including depreciation and amortisation, increased by approximately $194,000, or 1.7%, to $11.9 million for 2016 compared with $11.7 million for 2015.

General and administrative expenses decreased by approximately $636,000, or 7.8%, to $7.5 million for 2016 compared with $8.2 million for the prior year, primarily due to better operating efficiencies achieved from the integration of the SingleSource acquisition.

Selling and marketing expenses were reduced by approximately $175,000, or 11.9%, to $1.3 million (2015: $1.5 million), primarily due to the consolidation of the SingleSource sales and marketing team.

Research and development increased by approximately $863,000, or 107%, to $1.7 million for 2016 compared with $808,000 for 2015. This was primarily due to more products going into production, including Sphere, which changes the accounting treatment of much of the software development costs from being capitalised to being expensed.

Depreciation and amortisation increased by approximately $142,000, or 11%, to $1.4 million (2015: $1.3 million), primarily due to more products going into production, including Sphere, and thereby commencing amortising on the capitalised asset.

EBITDA for 2016 improved by $290,000 to a $666,000 loss, compared with $956,000 loss for the prior year. The Company reported a loss before tax of approximately $2.1 million in 2016 compared with a loss before tax of approximately $2.3 million for 2015.

As of 31 December 2016, total assets were $9.7 million with the largest assets being goodwill and other intangible assets of $5.0 million, net cash of $2.4 million, and accounts receivable of $1.4 million. For 2016, the Company utilised $1.5 million in cash compared with $2.6 million in the prior year, a 43% improvement in cash utilisation.

The Company's total liabilities as of 31 December 2016 were $1.6 million, and stockholders' equity was $8.1 million, resulting in a debt-to-equity ratio of 20%.

The Company utilised $460,000 in cash in operating activities compared with $1.0 million for the previous year, mainly due to improvement in working capital accounts. The Company used $0.9 million in investment activities compared with $1.5 million for the previous year. This reduction is primarily the result of lower capitalised software development costs as more products were brought into production during the course of the year. The Company paid $96,000 in financing activities related to capital lease obligations.

Outlook

2016 was a significant year for ClearStar as the Company streamlined its business, strengthened the direct sales team and launched its global platform. ClearStar now provides a suite of advanced services, directly and indirectly through our Channel Partner and CRA customers, on a global basis.

As a result, the Company entered 2017 well positioned with a stronger client base and a more comprehensive service offering compared with the previous year.

The fluidity of the labour market continues to expand thereby increasing the demand for ClearStar's direct services and providing new opportunities for revenue generation. The Company's global platform, Sphere, is gaining traction, with the strong initial client response strengthening management's belief in generating meaningful global revenue in 2017. Consequently, the Board is confident of delivering continued growth and shareholder value, and looks forward to updating the market as the year progresses.

 
 CLEARSTAR, INC. 
 Consolidated Statements of Operations 
 (USD, in thousands) 
                                           Year Ended              Year Ended 
                                            31 December            31 December 
                                               2016                    2015 
                                            (Unaudited) 
                                                $                      $ 
 
 Net revenue                                     16,032                         15,516 
 Cost of revenue                                  6,197                          6,023 
                                         --------------  ----------------------------- 
 
 Gross profit                                     9,835                          9,493 
                                         --------------  ----------------------------- 
 
 Operating expenses 
 Selling and marketing                            1,299                          1,474 
 Research and development                         1,671                            808 
 Depreciation and amortisation                    1,429                          1,287 
 General and administrative                       7,531                          8,167 
                                         --------------  ----------------------------- 
 
 Total operating expenses                        11,930                         11,736 
 
 Loss from operations                           (2,095)                        (2,243) 
                                         --------------  ----------------------------- 
 
 Other expense 
 Interest expense                                  (16)                           (22) 
                                         --------------  ----------------------------- 
 
 Total other expense                               (16)                           (22) 
                                         --------------  ----------------------------- 
 
 Net loss before taxes                          (2,111)                        (2,265) 
 
 Provision for income taxes                          61                             53 
 
 Net loss                                       (2,172)                        (2,318) 
                                         ==============  ============================= 
 
 
 CLEARSTAR, INC. 
 Consolidated Balance Sheets 
 (USD, in thousands) 
                                                     As of           As of 
                                                   31 December     31 December 
                                                      2016            2015 
                                                   (Unaudited) 
                                                       $               $ 
 ASSETS 
 Current assets 
 Cash                                                    2,420           3,893 
 Accounts receivable -- trade, net                       1,442           1,609 
 Research and development tax credits                      138              82 
 Prepaid expenses                                          257             291 
                                                --------------  -------------- 
 Total current assets                                    4,257           5,875 
                                                --------------  -------------- 
 Property and equipment, at cost 
 Computer equipment                                        687             749 
 Furniture and fixtures                                    277             279 
 Leasehold improvements                                     62              72 
 Less accumulated depreciation                           (560)           (412) 
                                                --------------  -------------- 
 Total property and equipment, net                         466             688 
                                                --------------  -------------- 
 Other assets 
 Goodwill and other intangible assets                    4,976           5,268 
 Deposits                                                   11              11 
                                                --------------  -------------- 
 Total other assets                                      4,987           5,279 
                                                --------------  -------------- 
 Total assets                                            9,710          11,842 
                                                ==============  ============== 
 
 LIABILITIES AND STOCKHOLDERS' EQUITY 
 Current liabilities 
 Accounts payable                                        1,130           1,203 
 Accrued liabilities                                       119              82 
 Deferred revenue                                           54              54 
 State income taxes                                          5               7 
 Current portion of obligations under 
  capital lease                                             99              92 
                                                --------------  -------------- 
 Total current liabilities                               1,407           1,438 
                                                --------------  -------------- 
 Long-term liabilities 
 Accrued liabilities                                        46              50 
 Deferred income taxes                                      99              45 
 Obligations under capital lease, net 
  of current portion                                        68             171 
                                                --------------  -------------- 
 Total long--term liabilities                              213             266 
                                                --------------  -------------- 
 Stockholders' equity 
 Common stock, $0.0001 par value; 100,000,000 
  shares authorised; 36,302,900 shares 
  issued and outstanding                                     4               4 
 Additional paid--in capital                            13,602          13,478 
 Accumulated deficit                                   (5,516)         (3,344) 
                                                --------------  -------------- 
 Stockholders' equity                                    8,090          10,138 
                                                --------------  -------------- 
 Total liabilities and stockholders' 
  equity                                                 9,710          11,842 
                                                ==============  ============== 
 
 
 CLEARSTAR, INC. 
 Consolidated Statements of Changes in Stockholders' Equity 
 (USD, in thousands, except no. of shares) 
                                                                     Additional 
                                 Common Stock                          Paid-in             Accumulated 
                        Shares                 Amount                 Capital                Deficit                Total 
                         No.                       $                               $                      $                    $ 
 
 Balances at 1 
  January 
  2015             36,302,900                               4             13,346                  (1,026)               12,324 
 
 Non-cash 
  stock 
  compensation                      -                      -                     132                      -                  132 
 
 Net loss                           -                      -                       -              (2,318)                (2,318) 
 
 Balances at 
  31 December 
  2015             36,302,900                               4                 13,478              (3,344)                 10,138 
 
 Non-cash 
  stock 
  compensation                      -                      -                     124                      -                  124 
 
 Net loss                           -                      -                       -                (2,172)              (2,172) 
 
 Balances at 
  31 December 
  2016 
  (unaudited)      36,302,900                               4                 13,602                (5,516)                8,090 
                =====================  ======================  =====================  =====================  =================== 
 
 
  CLEARSTAR, INC. 
 Consolidated Statements of Cash Flows 
 (USD, in thousands) 
 
                                                             Year Ended               Year Ended 
                                                              31 December              31 December 
                                                                 2016                     2015 
                                                              (Unaudited) 
                                                                  $                        $ 
 CASH FLOWS FROM OPERATING ACTIVITIES 
  Net loss                                                        (2,172)                           (2,318) 
       Adjustments to reconcile net loss 
       to net cash used for operating activities: 
   Change in allowance for doubtful accounts                           13                                 5 
   Depreciation and amortisation                                    1,429                             1,287 
   Deferred income taxes                                               54                                45 
   Non-cash stock compensation                                        124                               132 
             Loss on disposal of property and equipment                 2                                 - 
             Change in operating assets and liabilities: 
     Accounts receivable                                              154                             (518) 
     Research and development tax credits                            (56)                              (55) 
     Prepaid expenses                                                  34                              (79) 
     Deposits                                                           0                                 2 
     Accounts payable                                                (73)                               629 
     Accrued liabilities                                               33                              (87) 
     Deferred revenue                                                   -                              (48) 
     State income taxes                                               (2)                                 3 
 
        Total adjustments                                           1,712                             1,316 
                                                           --------------  -------------------------------- 
 
 Net cash used for operating activities                             (460)                           (1,002) 
                                                           --------------  -------------------------------- 
 
 CASH FLOWS FROM INVESTING ACTIVITIES 
  Acquisition of property and equipment                              (32)                              (96) 
       Proceeds from disposition of property 
        and equipment                                                   1                                 - 
  Capitalised software development costs                            (886)                           (1,396) 
 
 Net cash used for investing activities                             (917)                           (1,492) 
                                                           --------------  -------------------------------- 
 
 CASH FLOWS FROM FINANCING ACTIVITIES 
  Principal payments on capital lease 
   obligations                                                       (96)                              (90) 
                                                           --------------  -------------------------------- 
 
 Net cash provided used for financing 
  activities                                                         (96)                              (90) 
                                                           --------------  -------------------------------- 
 
 Net cash decrease for year                                       (1,473)                           (2,584) 
 
 Cash at beginning of year                                          3,893                             6,477 
 
 Cash at end of year                                                2,420                             3,893 
                                                           ==============  ================================ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

FR UBVKRBOAOUAR

(END) Dow Jones Newswires

March 28, 2017 02:01 ET (06:01 GMT)

1 Year Clrstar (DI/S) Chart

1 Year Clrstar (DI/S) Chart

1 Month Clrstar (DI/S) Chart

1 Month Clrstar (DI/S) Chart

Your Recent History

Delayed Upgrade Clock